9-Fluorenylmethoxycarbonyl (Fmoc)-amino acids and all other chemicals for the solid phase peptide synthesis. Rink Amide MBHA Resin (loading 0.64 mmol/g) was purchased from Novabiochem EMD Millipore and Fmoc-8-amino-3,6-dioxaoctanoic acid (Fmoc-O 2 Oc-OH) from Iris Biotech GMBH. Analytical high-performance liquid chromatography (HPLC) separations were performed on a Dionex Summit dual-gradient HPLC instrument, equipped with four-channel UV-Vis detector, using a Vydac 218TP54 column (250 x 4.6 mm, 5 μm, flow rate at 1.5 mL min −1 ). The mobile phase A (aqueous 0.1% Trifluoroacetic acid (TFA)) and B (90% aqueous acetonitrile containing 0.1% TFA) were used for preparing binary gradients. The elution condition was: isocratic 10% B for 3 min; linear gradient 10-90% B for 30 min. Preparative HPLC separations were performed on a Shimadzu series LC-6A chromatograph, equipped with two independent pump Electronic Supplementary Material (ESI) for Nanoscale Advances. This journal is
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Synthesis of Peptide GE11-C
The peptide sequence YHWYGYTPQNVI-O 2 Oc-C-NH 2 (GE11-C) was prepared on an automated Advanced Chemtech 348 Ω peptide synthesizer, using Fmoc Chemistry and a Rink amide MBHA resin (0.64 mmol g −1 ). The amino acid side chains were protected by the tert-butyl group (tyrosine and threonine), the tertbutyloxycarbonyl group (tryptophan) and the trityl group (histidine, glutamine, asparagine, and cysteine). Fmoc deprotection was achieved with 20% piperidine in DMF (5 + 15 min). Couplings were carried out in DMF, using an excess of the Fmoc-amino acid (4 eq) and in the presence of N-hydroxybenzotriazole, N,N,N′,N′-tetramethyl-O-(1Hbenzotriazol-1-yl) uroniumhexafluorophosphate, and N,N,N-ethyldiisopropylamine (4:4:12 eq) for 45 min. Cleavage and deprotection of peptides from the solid support was achieved by treatment with a mixture of TFA/triisopropylsilane/H 2 O/1,2-ethanedithiol (94:1:2.5:2.5 v/v/v/v) for 1 h and 30 min at room temperature (RT). The resin was filtered off, the acid solution was reduced to a small volume and the crude peptide was precipitated by an addition of cold diethyl ether. Peptides were purified by semipreparative HPLC. The elution condition was: isocratic 27% B for 5 min: linear gradient 27-25% B for 20 min. The purified product was characterized by analytical HPLC and high resolution mass spectrometry (HRMS) electrospray ionization (ESI) (Table S1 and Fig. S1 †) . Table S1 . Analytical data of the peptide ligand. a Abbreviations: O 2 Oc, 8-amino-3,6-dioxoactanoic acid; In the sequence, the one-letter symbols for amino acids have been used. b For Analytical HPLC and HRMS spectra see Fig. S1 †.
Preparation of SERRS Nanostructures

Synthesis of SERRS Nanoaggregates and of the Reference AuNP@PEG-SH Nanostructures.
Peptide
Sequence 
Molecular Dynamic Simulation
MD simulations performed considering a monolayer with only PEG-SH on an Au surface, showed that the polymers form a carpet, thus inhibiting any further specific binding on the gold surface (data not shown). In the case of GE11-C only, 36 peptides (maximum value due to steric hindrance) can be placed on the simulated box of 5 x 5 x 12 nm 3 , with the thiol group constrained near the Au surface. Some regions of the amino acid sequence can adopt parallel beta sheets (Fig. S3 ). These structural arrangements can be considered responsible for the targeting activity but not selectivity of GE11-C coated AuNPs (AuNP@GE11-C). Simulations of monolayer containing both PEG-SH and GE11-C (molar ratio 1:1) showed that the addition of PEG-SH destabilizes the GE11-C assembly above described, causing a decrease in the population of parallel beta sheet conformation and a consequent formation of an irregular mixture on the Au surface. 
